Pages that link to "Q51600159"
Jump to navigation
Jump to search
The following pages link to Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel (Q51600159):
Displaying 50 items.
- Free testosterone drives cancer aggressiveness: evidence from US population studies (Q27324026) (← links)
- Yield of laboratory tests for case-finding in the ambulatory general medical examination (Q28286924) (← links)
- Hyperlipidemia: Part 1. Evaluation and dietary management (Q28360469) (← links)
- The physician and pharmacist team. An effective approach to cholesterol reduction (Q30446426) (← links)
- Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Lipid-lowering drugs, cost-effectiveness data, and the formulary system: a health systems perspective (Q30573715) (← links)
- Evaluation of the Heart To Heart Project: lessons from a community-based chronic disease prevention project (Q30663687) (← links)
- A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data (Q30667146) (← links)
- The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (Q31129827) (← links)
- Selective estrogen receptor modulators: Women's panacea for the next millennium? (Q33540949) (← links)
- Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis (Q33566590) (← links)
- The health impact of worksite nutrition and cholesterol intervention programs (Q33573096) (← links)
- Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease (Q33645696) (← links)
- An alternative treatment of hyperlipidemia with red yeast rice: a case report (Q33663590) (← links)
- Managing dyslipidemia in older adults (Q33790720) (← links)
- The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women (Q33845784) (← links)
- Benefits of lipid-lowering agents in stroke and coronary heart disease: pharmacoeconomics (Q34107382) (← links)
- Nutritional interventions in cardiovascular disease: new challenges and opportunities (Q34107618) (← links)
- Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia (Q34112932) (← links)
- Lipid screening in a managed care population. (Q34199204) (← links)
- Screening and treating adults for lipid disorders. (Q34221135) (← links)
- Clinical context: current concepts of coronary heart disease management (Q34224519) (← links)
- Lipid-lowering interventions in managed care settings (Q34224541) (← links)
- Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity (Q34238357) (← links)
- Management of hypercholesterolaemia in postmenopausal women (Q34655133) (← links)
- Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction (Q34742822) (← links)
- Lipoprotein abnormalities related to women's health (Q34990631) (← links)
- Comparing changes in health risk factors and medical costs over time (Q35020108) (← links)
- Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor? (Q35036478) (← links)
- Behavioral medicine in the prevention and treatment of cardiovascular disease (Q35066557) (← links)
- Combinations of biomarkers predictive of later life mortality (Q35080505) (← links)
- Xuefuzhuyu decoction for hyperlipidemia: a systematic review and meta-analysis of randomized clinical trails (Q35237658) (← links)
- Undertreatment of hypercholesterolaemia: a population-based study (Q35825259) (← links)
- Metabolic risks in older adults receiving second-generation antipsychotic medication (Q37383679) (← links)
- Dyslipidemia in women: etiology and management (Q37582481) (← links)
- Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. (Q39652119) (← links)
- Challenges in making therapeutic lifestyle changes among hypercholesterolemic African-American patients and their physicians. (Q39782220) (← links)
- Particle size of LDL is affected by the National Cholesterol Education Program (NCEP) step II diet in dyslipidaemic adolescents (Q40221771) (← links)
- Cholesterol in patients with coronary heart disease: how low should we go? (Q40368068) (← links)
- Extending the benefit of lipid-regulating therapy to primary prevention (Q40421142) (← links)
- Nutrition and Coronary Heart Disease Epidemiology (Q40436417) (← links)
- Preventing and arresting coronary atherosclerosis (Q40474642) (← links)
- Update on the treatment of hypercholesterolemia, with a focus on hmg‐coa reductase inhibitors and combination regimens (Q40476568) (← links)
- The 4S study. Implications for prescribing (Q41032417) (← links)
- Gender differences in percutaneous interventional therapy of coronary artery disease (Q41082200) (← links)
- Adults aged 20 and older should have their cholesterol measured (Q41526083) (← links)
- Cholesterol Management in Theory and Practice (Q41673527) (← links)
- The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines (Q41689996) (← links)
- Cholesterol and coronary heart disease in women (Q41723397) (← links)
- Reaching National Cholesterol Education Program Goals: a managed care approach to improving hyperlipidemia disease management outcomes. Introduction (Q43580760) (← links)
- Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome (Q43832908) (← links)